Clinical Trial

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

Study acronym: FETO
Recruiting
View on ClinicalTrials.gov →
Summary
The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2015-08-19; most recent amendment 2026-06-16.
Status change: Not Yet Recruiting → Recruiting 2016-02-22
Trial Details
NCT Number NCT02530073
Lead Sponsor Connecticut Children's Medical Center
Conditions Congenital Diaphragmatic Hernias
Enrollment 15 participants
Start Date 2015-09
Primary Completion 2028-08 (estimated)
Study Completion 2030-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-18